Da-Cheng-Qi decoction (DCQD) is a purgative prescription used in China and East Asia. To profile the constituents of this complex traditional Chinese medicine (TCM), a high-performance liquid chromatographic, electrospray ionization, tandem mass spectrometric (HPLC-ESI/MS/MS) analytical method was developed. After separation on a reversed-phase C18 analytical column using gradient elution, samples were analyzed by ESI-MS/MS in negative mode. As a result, a total of 37 compounds were detected, of which two tannins, three anthraquinones, two sennosides, five flavonoids and two lignans were unambiguously identified by comparison with standard compounds, and sixteen compounds were either tentatively identified or deduced according to their MS/MS data. The fragmentation pathways of many of the observed compounds, such as the tannins and lignans are reported for the first time. In addition, the identity of each peak in DCQD was explored by comparison with those of its three constituent herbs. The results indicated that tannins, anthraquinones and sennosides in DCQD originated from Radix et Rhizoma Rhei, flavonoids from Fructus Aurantii Immaturus, and lignans from Cortex Magnoliae officinalis. The present study provides an example of chemical constitution profiling in complex TCM systems using LC/MS/MS.
Described in Shang-Han-Lun (Treatise on Cold damage Diseases, a Chinese medicine classic from the Han dynasty), Da-Cheng-Qi decoction (DCQD) is a well known purgative formula consisting of four natural medicines [Radix et Rhizoma Rhei (Dahuang) , Cortex Magnoliae officinalis (Houpu), Fructus Aurantii Immaturus (Zhishi) and Natrii Sulfas (Mangxiao)] [1a] . Nowadays, DCQD is usually used to treat diseases such as acute intestinal obstruction without complications, acute cholecystitis and appendicitis [1b] . DCQD is also used in treating posttraumatic respiratory distress syndrome [1c] , reducing acute-phase protein levels in patients with multiple organ failure syndromes [1d], and relieving inflammation in patients after a tumor operation [1e] . Recently DCQD was found to possess anti-inflammatory effects as well as its purgative activities [1f] . It is accepted that the bioactivities of TCM are not the effect of either a single compound or a class of compounds, but the synergistic effects of all the compounds, major and minor, in the herbs. Thus, if we want to reveal the action mechanism of DCQD, we must first investigate the active chemical components. Hence sensitive analytical techniques are needed to gain a better understanding of the pharmacological basis of the TCM and enhance product quality control. Recently, LC/MS has shown its wide application in TCM research because this technique is powerful to analyze natural plant secondary metabolites [2a-2c] . Multi-stage MS analysis provides structure information even when the compounds are present in trace amounts. This facilitates the identification of known and unknown components of the herb extracts, even without a MS database.
Several papers have been published about component identification in DCQD's constitutional herbs using LC/MS methods. Ye et al [3a] and Zhou et al [3b] , using liquid chromatography coupled with electrospray ionization mass spectrometry, analyzed the phenolic compounds in methanol extracts of Rhubarb, and the flavonoids in water-ethanol extracts of Citrus aurantium L, respectively. In addition, Jin et al [3c] reported an HPLC-DAD/MS fingerprint method to control the quality of Rheum tanguticum Maxim. ex Balf. B. from different sources. However, no study has been conducted to profile all the chemical constituents in DCQD using LC/MS. So, this study was aimed to develop a LC-ESI/MS/MS method to profile the chemical constitutions of DCQD and assign the various peaks to compounds in the corresponding raw materials.
In the LC/MS total ion current chromatogram (TIC) of DCQD, thirty-seven major peaks were observed, among which peaks 3, 7, 10, 12, 14, 16, 17, 18, 22, 23 and 27 were derived from Fructus Aurantii Immaturus, peaks 5, 25, 31, 34, 36 and 37 from Cortex Magnoliae officinalis, and peaks 1, 2, 4, 6, 8, 9, 11, 13, 15, 19, 20, 21, 24, 26, 28, 29, 30, 32, 33 and 35 from Radix et Rhizoma Rhei. The retention times, raw materials ascription, and mass spectral data are summarized in Table 1 . Peaks 7, 10, 12, 14, 16, 17, 18, 22, 23 and 27 were all identified as flavonoids derived from Fructus Aurantii Immaturus. The extracted ion chromatograms (EIC) for m/z 595, 579 and 609 indicate that peak 7 vs peak 10, peak 12 vs peak 14, and peak 16 vs peak 18 are three pairs of isomers (Figure1S, in supporting information).
Peaks 14, 16 and 18 were unambiguously identified as naringin, hesperidin and neohesperidin, respectively, by comparison with standard compounds. Our previous studies showed that the same aglycones with rutinose had lower retention times under the same chromatographic conditions than those with neohesperidose [3d]. Based on this hypothesis, peak 12 was proposed as isonaringin, the isomer of naringin (peak 14). In addition, peaks 7 and 10 were proposed as eriocitrin and neoeriocitrin, respectively. The MS/MS data of peaks 7, 10 and 12 confirmed the above presumption.
Peak 17, eluted at 91.2 min, gave rise to the deprotonated molecule [M-H]at m/z 463. The product ion at m/z 301 indicated the presence of aglycones of hesperetin, which was proposed as being formed through the loss of glucose from the ion at m/z 463. Thus, peak 17 was tentatively identified as hesperetin-7glucoside.
The fragmentation behavior of the [M-H]ion at m/z 593 for peak 23 was in agreement with that of poncirin. The product ions at m/z 473 and 431 were generated through the loss of 120 and glucose, respectively, from the m/z 593 ion. A further loss of rhamnose from the m/z 431ion gave rise to the ion at m/z 285.
Peaks 22 and 27 were unambiguously identified as naringenin and hesperetin, respectively, by comparison with standard compounds, based on retention time and MS/MS. The proposed fragmentation pathways can be found in Figures 2S and 3S (supporting information). 245,227,205.203,187, 179,161,151,125,123,109 (-) 258, 257, 242, 227, 215, 200, 199, 185, 164, 151, 134, 125 hesperetin* ZS Five peaks (25, 31, 34, 36 and 37) were identified as lignans deriving from Cortex Magnoliae officinalis. Figure 1 shows the EIC for the ions at m/z 265, which demonstrates that peaks 34, 36 and 37 might be one group of isomers. Peaks 34 and 36 were unambiguously identified as honokiol and magnolol, respectively, by comparison with standard compounds. These three isomers showed very different MS fragmentation pathways, which could be used to identify them. For honokiol (peak 34), ions at m/z 250, 247, 237, 224 and 209 were the major fragment ions from its [M-H]ion at m/z 265 in the MS/MS spectra, among which ions at m/z 250, 247, 237 and 224 were proposed to result from the loss of CH 3 ·, H 2 O, CO and CH 2 =CHCH 2 ·, respectively from the m/z 265 ion. Peak 36 (magnolol), eluted at 171.3 min, gave rise in the MS/MS to ions at m/z 247 and 245 from its [M-H]ion at m/z 265, of which the ion at m/z 247 was generated through the loss of H 2 O from the ion at m/z 265. The MS/MS spectra of peak 37 (isomagnolol) showed that ions at m/z 247 and 97 were the major product ions of its [M-H]ion. The ion at m/z 247 was also proposed as coming from the [M-H]ion at m/z 265, by loss of water, while the ion at m/z 97 was considered as having been generated from the m/z 265 ion by loss of C 6 H 4 CH 2 CHCH 2 · and C 4 H 5 . Figure 2 summarizes the proposed fragmentation pathways of these three isomers, although the three compounds could all generate product ions at m/z 247, but the mechanisms were different. For magnolol, the ion at m/z 247 resulted mainly through the loss of H 2 O between 2 and 2' OH, while for honokiol and isomagnolol, these ions were generated mainly between OH and its ortho-H.
Peak 25 (129.60 min) was tentatively identified as magnolignan A, based on its mass spectrometric fragmentation behavior ( Figure 4S , supporting information Two sennosides and three anthraquinones ( Figure 5S , supporting information) were unambiguously identified in DCQD using standard compounds [peak 15 (t R =86.87 min), peak 20 (t R =105.0 min), peak 30 (t R =152.90 min), peak 33 (t R =161.97 min) and peak 35 (t R =169.8 min)] were identified as sennoside B, sennoside A, aloe emodin, rhein and emodin, respectively.
Apart from the above mentioned sennosides and anthraquinones, two anthraquinone glycosides were also identified according to their fragmentation behavior ( Figure 6S, supporting them are summarized in Figures 3 and 4 , respectively. Gallic acid (peak 1) gave a significant [M-H]ion at m/z 169 in the negative ion mode. The ion at m/z 125 in the MS/MS spectra was yielded through the loss of CO 2 from the m/z 169 ion, the further loss of H 2 O and CO leading to ions at m/z 107 and 97, respectively. The ion at m/z 81 was formed from the ion at m/z 107 through a loss of C 2 H 2 , while the ion at m/z 79 was generated from that at m/z 97 through the loss of H 2 O. So, the fragmentation pathways 169→125→107→81 or 169→125→97→79 could be used as the evidence to demonstrate the presence of the gallic acid structure. The MS/MS spectra of (-)-epicatechin {(peak 2) [M-H]at m/z 289} were very complicated and ions at m/z 271, 245, 227, 205, 203, 187, 179, 161, 151, 125, and 123, 109 Except for gallic acid and (-)-epicatechin, the other six peaks (4, 6, 8, 9, 19 and 21) were tentatively identified based on their MS/MS spectra and fragmentation behavior. The [M-H]of peak 4 was at m/z 309; the further loss of glucose (162u) yielded the ion at m/z 147, which was in agreement with the fragmentation pathway of 2-cinnamoyl-glucose. The ion at m/z 147 could be used as evidence to indicate the presence of the cinnamic acid structure.
The [M-H]ion at m/z 441 (peak 6) produced nine fragment ions at m/z 331, 289, 271, 245, 225, 193, 169, 161 and 125 . The existence of two groups of characteristic fragment ions i.e. m/z 169, and 125, and 289, 271, 245, 225 , and 161 demonstrated the presence of structure groups of gallic acid and catechin, respectively. So, peak 6 was proposed as a derivative of gallic acid and catechin, i.e. (-)-epicatechin-3-O-gallate.
The fragment ions at m/z 331, 289 and 169 were yielded from ions at m/z 441 through the loss of pyrocatechol, galloyl and epicatechin, respectively. The generation mechanisms of the other ions were the same as for gallic acid and epicatechin ( Figure 7S , supporting information).
Peak 19 (96.0 min) gave rise to the [M-H]ions at m/z 461 ion, which produced three major ions at m/z 313, 169 and 147. The existence of the ions at m/z 169 and 147 indicated that peak 19 might be a derivative of gallic acid and cinnamoyl. The molecular weight and the fragmentation pathway ( Figure 8S , supporting information) of peak 19 were in agreement with 2-Ocinnamoyl-glucogallin that is found in Rheum.
The [M-H]ion at m/z 613 of peak 21 (117.4 min) produced product ions at m/z 465, 369 and 313. The presence of the ion at m/z 313 indicated that peak 21 might contain the same structure group i.e. glucogallin as compound 19. The mass difference between the [M-H]of peaks 21 and 19 was 152, which indicates the existence of another galloyl structure. So there were two galloyl, one cinnamoyl and one glucose groups in compound 21, which was in agreement with 1,6digalloyl-2-cinnamoyl-glucose, which is a constituent of Rheum. Figure 9S (supporting EIC shows that peaks 8 and 9 were one pair of isomers with the same [M-H]at m/z 477. From the above fragmentation pathway discussion of peaks 19 and 21 we could deduce that the product ions at m/z 313 and 169 indicate the presence of galloyl-glucose. The difference in weight between 477 and galloyl-glucose [M-H]m/z 331 was 146u, which indicates that this might represent one rhamnose. From the above discussion of flavonoid glycosides we concluded that rutinose and neohesperidose was one pair of isomers constructed of rhamnose and glucose, which only differed by the interglycosidic linkage type between the two monosaccharides. At the same time we found that the same aglycones with rutinose would contribute less than that with neohesperidose in the aspect of the chromatography retention time under the same chromatographic conditions. So peaks 8 and 9 were proposed as galloyl-rutinoside and galloyl-neohesperidoside, respectively, which is reported for the first time.
Experimental
Reagents and reference standards: Magnolol (Batch No: 110729-200309 
Preparation of Da-Cheng-Qi decoction and single natural medicine decoction:
The DCQD was prepared according to the method and procedure described in Shang-Han-Lun and was optimized [3d,3e,4] : the bark of Cortex Magnoliae officinalis (24 g) and Fructus Aurantii Immaturus (15 g) were immersed in 300 mL distilled water and boiled until half of the original amount was left. This procedure was repeated. The two water extracts were combined. Radix et Rhizoma Rhei (12 g) was then immersed in the combined water extracts and boiled until half of the original amount was left and then Natrii Sulfas (6 g) was dissolved in the water extract. The extract was filtered and diluted to 250 mL with distilled water and stored at 4 o C until use. Single herb decoction was also prepared according to the preparation procedure of DCQD mentioned above, but without the other raw drugs. From the above prepared decoction 1 mL and 1 mL DMSO were transferred to a 5 mL flask. After vortex extraction (3 min), the mixture was diluted to volume with water. The resultant solution was filtered through a 0.45 µm membrane filter before HPLC analysis. Instrumentation and operation conditions: LC-ESI/MS experiments were conducted using a Finnigan Surveyor HPLC system (Thermo Electron, San Jose, CA, USA) equipped with a Finnigan autosampler. The mobile phase consisted of (A) 0.2 % aqueous formic acid and (B) methanol: acetonitrile (3:2) using a linear gradient (as shown in table 2). Chromatography was carried out on an Agilent Zorbax SB-C18 column (5 µm, 25 0 mm× 4.6 mm) at 35°C column temperature. The flow rate was 1.0 mL/min. The HPLC eluant from the column was introduced into the mass spectrometer via a 1:4 split. The mass detection was conducted using a Finnigan TSQ Quantum Discovery max system (Thermo Electron, San Jose, CA, USA) equipped with an electrospray ionization source. The acquisition parameters for negative modes were: collision gas, ultrahigh-purity helium (He); nebulizing gas, high purity nitrogen (N 2 ); ion spray voltage -4.5 kV, sheath gas (N 2 ) 40 arbitrary units; auxiliary gas (N 2 ) 5 arbitrary units; capillary temperature 350°C; capillary voltage -15 V; tube lens offset voltage -30 V; mass range recorded m/z 40-1000. Data-dependent MS/MS scanning was used in negative ion mode so that the 3 most abundant ions in each MS scan were selected in turn and subjected to tandem mass spectrometric analyses. The collision energy for collision-induced dissociation was set at 25 V with collision gas at a pressure of 1.5 m Torr.
Supporting information - Figure 1S . Extracted ion chromatogram for 595 (A), 579 (B) and 609 (C); Figure  2S . Proposed fragmentation pathway of naringenin; Figure 3S . Proposed fragmentation pathway of hesperetin; Figure 4S . Proposed fragmentation pathway of magnolignan D (A) and magnolignan A (B); Figure  5S . Proposed fragmentation pathway of emodin (A), aloe emodin (B) and rhein(C); Figure 6S . Proposed fragmentation pathway of physcion-8-glucoside (A) and chrysophanol-8-O-β-D-glucopyranoside (B); Figure 7S . Proposed fragmentation pathway of (-)-epicatechin-3-O-gallate; Figure 8S . Proposed fragmentation pathway of 2-O-cinnamoyl-glucogallin; Figure 9S . Proposed fragmentation pathway of 1,6-digalloyl-2-cinnamoylglucose.
